Genmab A/S is listed on the NASDAQ Copenhagen A/S under the ticker symbol GEN and is traded as part of the OMXC20. Genmab is committed to proactive interaction with our shareholders and to provide reliable and transparent information about our business, development programs and results in an open and timely manner. In this area you can find information about Genmab's latest share price, our recent news flow and other relevant shareholder information related to our listing on Nasdaq.

Latest News

Genmab news

Read Genmab's latest Company Announcements and Media Releases

Stock information

Including Genmab's share price, analyst coverage, major shareholders and warrant program

Download Library

Download library

Access Genmab's financial reports, webcasts, presentations and more

Upcoming events and presentations

Upcoming events and presentations

Find detailed information about conferences & events Genmab participates in


AGM 2017

Please click here for more information about Genmab’s 2017 Annual General Meeting.




To register your email address for electronic shareholder communications or to update your settings, log on to the InvestorPortal in Danish or English

ADR Program

ADR Program

Find out more about Genmab's new ADR Program